Wear of hip prostheses increases serum IGFBP-1 levels in patients with aseptic loosening

Abstract The biological mechanisms involved in aseptic loosening include inflammation-associated and bone resorption-associated processes. Coordinated cellular actions result in biochemical imbalances with devastating consequences for the joint. Given that this condition is not known for showing sys...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Gema Vallés, Eduardo García-Rey, Laura Saldaña, Eduardo García-Cimbrelo, Nuria Vilaboa
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/f6d712953212402db4e158256b05b981
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:f6d712953212402db4e158256b05b981
record_format dspace
spelling oai:doaj.org-article:f6d712953212402db4e158256b05b9812021-12-02T15:23:08ZWear of hip prostheses increases serum IGFBP-1 levels in patients with aseptic loosening10.1038/s41598-020-79813-x2045-2322https://doaj.org/article/f6d712953212402db4e158256b05b9812021-01-01T00:00:00Zhttps://doi.org/10.1038/s41598-020-79813-xhttps://doaj.org/toc/2045-2322Abstract The biological mechanisms involved in aseptic loosening include inflammation-associated and bone resorption-associated processes. Coordinated cellular actions result in biochemical imbalances with devastating consequences for the joint. Given that this condition is not known for showing systemic signs, we investigated whether circulating levels of inflammation-related proteins are altered in patients with aseptic loosening. Our study included 37 patients who underwent revision surgery due to hip osteolysis and aseptic loosening and 31 patients who underwent primary total hip arthroplasty. Using antibody arrays, we evaluated the serum levels of 320 proteins in four patients from each group. The results showed differences in insulin-like growth factor-binding protein 1 (IGFBP-1) concentrations, which we then quantified using enzyme-linked immunosorbent assay tests in all study patients. The results confirmed that serum IGFBP-1 concentrations were higher in the revision surgery patients than in the hip arthroplasty patients. In vitro studies showed that exposure of human osteoblasts to titanium particles induced an IGFBP-1 release that further increased when exposure to particles was performed in media conditioned by human M1 macrophages. These findings suggest that elevated serum IGFBP-1 levels in patients with aseptic loosening can arise from increased local IGFBP-1 production in the inflammatory environment of the periprosthetic bed.Gema VallésEduardo García-ReyLaura SaldañaEduardo García-CimbreloNuria VilaboaNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-13 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Gema Vallés
Eduardo García-Rey
Laura Saldaña
Eduardo García-Cimbrelo
Nuria Vilaboa
Wear of hip prostheses increases serum IGFBP-1 levels in patients with aseptic loosening
description Abstract The biological mechanisms involved in aseptic loosening include inflammation-associated and bone resorption-associated processes. Coordinated cellular actions result in biochemical imbalances with devastating consequences for the joint. Given that this condition is not known for showing systemic signs, we investigated whether circulating levels of inflammation-related proteins are altered in patients with aseptic loosening. Our study included 37 patients who underwent revision surgery due to hip osteolysis and aseptic loosening and 31 patients who underwent primary total hip arthroplasty. Using antibody arrays, we evaluated the serum levels of 320 proteins in four patients from each group. The results showed differences in insulin-like growth factor-binding protein 1 (IGFBP-1) concentrations, which we then quantified using enzyme-linked immunosorbent assay tests in all study patients. The results confirmed that serum IGFBP-1 concentrations were higher in the revision surgery patients than in the hip arthroplasty patients. In vitro studies showed that exposure of human osteoblasts to titanium particles induced an IGFBP-1 release that further increased when exposure to particles was performed in media conditioned by human M1 macrophages. These findings suggest that elevated serum IGFBP-1 levels in patients with aseptic loosening can arise from increased local IGFBP-1 production in the inflammatory environment of the periprosthetic bed.
format article
author Gema Vallés
Eduardo García-Rey
Laura Saldaña
Eduardo García-Cimbrelo
Nuria Vilaboa
author_facet Gema Vallés
Eduardo García-Rey
Laura Saldaña
Eduardo García-Cimbrelo
Nuria Vilaboa
author_sort Gema Vallés
title Wear of hip prostheses increases serum IGFBP-1 levels in patients with aseptic loosening
title_short Wear of hip prostheses increases serum IGFBP-1 levels in patients with aseptic loosening
title_full Wear of hip prostheses increases serum IGFBP-1 levels in patients with aseptic loosening
title_fullStr Wear of hip prostheses increases serum IGFBP-1 levels in patients with aseptic loosening
title_full_unstemmed Wear of hip prostheses increases serum IGFBP-1 levels in patients with aseptic loosening
title_sort wear of hip prostheses increases serum igfbp-1 levels in patients with aseptic loosening
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/f6d712953212402db4e158256b05b981
work_keys_str_mv AT gemavalles wearofhipprosthesesincreasesserumigfbp1levelsinpatientswithasepticloosening
AT eduardogarciarey wearofhipprosthesesincreasesserumigfbp1levelsinpatientswithasepticloosening
AT laurasaldana wearofhipprosthesesincreasesserumigfbp1levelsinpatientswithasepticloosening
AT eduardogarciacimbrelo wearofhipprosthesesincreasesserumigfbp1levelsinpatientswithasepticloosening
AT nuriavilaboa wearofhipprosthesesincreasesserumigfbp1levelsinpatientswithasepticloosening
_version_ 1718387363346907136